Literature DB >> 15046533

A guide to the treatment of adults with ADHD.

Margaret D Weiss1, Jacqueline R Weiss.   

Abstract

While child and adolescent physicians are familiar with the treatment of attention-deficit/hyperac-tivity disorder (ADHD), many adult physicians have had little experience with the disorder. It is difficult to develop clinical skills in the management of residual adult manifestations of developmental disorders without clinical experience with their presentation in childhood. Adult patients are increasingly seeking treatment for the symptoms of ADHD, and physicians need practice guidelines. Adult ADHD often presents differently from childhood ADHD. Because adult ADHD can be comorbid with other disorders and has symptoms similar to those of other disorders, it is important to understand differential diagnoses. Physicians should work with patients to provide feedback about their symptoms, to educate them about ADHD, and to set treatment goals. Treatment for ADHD in adults should include a medication trial, restructuring of the patient's environment to make it more compatible with the symptoms of ADHD, and ongoing supportive management to address any residual impairment and to facilitate functional and developmental improvements.

Entities:  

Mesh:

Year:  2004        PMID: 15046533

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  24 in total

1.  Challenges in identifying and managing attention-deficit/hyperactivity disorder in adults in the primary care setting: a review of the literature.

Authors:  Larry Culpepper; Gregory Mattingly
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

Review 2.  Pharmacokinetic variability of long-acting stimulants in the treatment of children and adults with attention-deficit hyperactivity disorder.

Authors:  James C Ermer; Ben A Adeyi; Michael L Pucci
Journal:  CNS Drugs       Date:  2010-12       Impact factor: 5.749

3.  A randomized, double-blind, cross-over, phase IV trial of oros-methylphenidate (CONCERTA(®)) and generic novo-methylphenidate ER-C (NOVO-generic).

Authors:  Angelo Fallu; Farida Dabouz; Melissa Furtado; Leena Anand; Martin A Katzman
Journal:  Ther Adv Psychopharmacol       Date:  2016-05-01

Review 4.  Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults.

Authors:  Paramala J Santosh; Sanjida Sattar; Myooran Canagaratnam
Journal:  CNS Drugs       Date:  2011-09-01       Impact factor: 5.749

5.  Impaired reward processing in the human prefrontal cortex distinguishes between persistent and remittent attention deficit hyperactivity disorder.

Authors:  Friedrich Wetterling; Hazel McCarthy; Leonardo Tozzi; Norbert Skokauskas; John P O'Doherty; Aisling Mulligan; James Meaney; Andrew J Fagan; Michael Gill; Thomas Frodl
Journal:  Hum Brain Mapp       Date:  2015-08-19       Impact factor: 5.038

6.  The relation between procrastination and symptoms of attention-deficit hyperactivity disorder (ADHD) in undergraduate students.

Authors:  Hannah C M Niermann; Anouk Scheres
Journal:  Int J Methods Psychiatr Res       Date:  2014-07-03       Impact factor: 4.035

Review 7.  Clinical recommendations in current practice guidelines for diagnosis and treatment of ADHD in adults.

Authors:  Christopher Gibbins; Margaret Weiss
Journal:  Curr Psychiatry Rep       Date:  2007-10       Impact factor: 5.285

8.  How do different diagnostic criteria, age and gender affect the prevalence of attention deficit hyperactivity disorder in adults? An epidemiological study in a Hungarian community sample.

Authors:  István Bitter; Viktoria Simon; Sára Bálint; Agnes Mészáros; Pál Czobor
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-10-06       Impact factor: 5.270

9.  Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit/hyperactivity disorder.

Authors:  Lenard A Adler; David Goodman; Richard Weisler; Mohamed Hamdani; Thomas Roth
Journal:  Behav Brain Funct       Date:  2009-08-03       Impact factor: 3.759

10.  The safety and efficacy of methylphenidate and dexmethylphenidate in adults with attention deficit/hyperactivity disorder.

Authors:  Michael A Sopko; Harjeet Caberwal; Benjamin Chavez
Journal:  J Cent Nerv Syst Dis       Date:  2010-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.